FREDERICK KARLO SORDILLA: Open Payments
NPI 1184314858 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,917 in 34 payments from 12 companies in 2025. Trend: 2023 $39 · 2024 $318 · 2025 $1,917
Food & beverage: $1,838Education: $79
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $561 |
| ABBVIE INC. | 3 | $310 |
| Madrigal Pharmaceuticals | 3 | $203 |
| Phathom Pharmaceuticals, Inc. | 2 | $171 |
| Lilly USA, LLC | 2 | $144 |
| Ardelyx, Inc. | 1 | $122 |
| QOL Medical, LLC | 1 | $122 |
| Ipsen Biopharmaceuticals, Inc | 1 | $106 |
| Janssen Biotech, Inc. | 1 | $79 |
| Aimmune Therapeutics, Inc. | 1 | $60 |
Products named: XIFAXAN, REZDIFFRA, VOQUEZNA, IBSRELA, Sucraid, RINVOQ, SKYRIZI, IQIRVO.
Industry payments across CA — which companies pay providers there.
